Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,651 | 12,589 | 66,574 | 24,698 | 29,113 |
| Marketable Securities | 99,607 | 107,921 | 59,029 | 53,157 | N/A |
| Other current assets | 1,611 | 1,311 | 421 | 382 | 249 |
| TOTAL | $114,201 | $122,616 | $127,318 | $79,885 | $29,839 |
| Non-Current Assets | |||||
| PPE Net | 245 | 170 | 68 | 34 | 42 |
| Investments And Advances | 0 | 0 | 0 | 1,000 | 0 |
| Other Non-Current Assets | 1,759 | 229 | 975 | 495 | 505 |
| TOTAL | $2,004 | $399 | $1,043 | $1,529 | $547 |
| Total Assets | $116,205 | $123,015 | $128,361 | $81,414 | $30,386 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7,482 | 7,000 | 7,000 | 7,000 | 7,000 |
| Accounts payable and accrued liabilities | 1,983 | 2,857 | 2,333 | 3,938 | 1,738 |
| Accrued Expenses | 3,474 | 3,518 | 5,249 | 4,403 | 3,881 |
| Other current liabilities | N/A | N/A | N/A | N/A | 125 |
| TOTAL | $13,201 | $13,400 | $14,641 | $15,433 | $12,867 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 2,151 | 3,800 | 5,428 | 7,056 |
| Other Non-Current Liabilities | 1,148 | 5 | 17 | 38 | 0 |
| TOTAL | $1,272 | $2,156 | $3,817 | $5,466 | $7,056 |
| Total Liabilities | $14,473 | $15,556 | $18,458 | $20,899 | $19,923 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,070 | 60,045 | 59,923 | 42,771 | 38,686 |
| Common Shares | 60 | 60 | 58 | 40 | 31 |
| Retained earnings | -216,470 | -210,069 | -204,564 | -196,298 | -188,246 |
| Other shareholders' equity | -88 | -122 | -263 | -135 | 0 |
| TOTAL | $101,732 | $107,459 | $109,903 | $60,515 | $10,463 |
| Total Liabilities And Equity | $116,205 | $123,015 | $128,361 | $81,414 | $30,386 |